Abstract
Purpose: Our purpose was to assess the endocrine status of women with polycystic ovaries (PCO) undergoing IVF, and to compare oocyte quality with endocrine markers of the syndrome, in an attempt to define a subpopulation with poor quality oocytes.
Methods: This was a retrospective study. Patients were first endocrinologically analyzed: serum levels of androgens (T, androstenedione, DHEAS), FSH, and LH as well as glucose and insulin after an oral glucose tolerance test (OGTT) were recorded and are expressed as absolute values and area under the curve (AUC). Subsequently, they were followed over a 2-year period in which patients underwent several attempts of IVF as well as serving as oocyte donors. Patients were divided into three groups: group I (n=4) was women who displayed embryos unable to implant in 15 IVF cycles and 10 ovum donation cycles in which they served as donors; group II (n=16) was PCO patients in whom IVF (n=38) and/or oocyte donation cycles (n=42) resulted in pregnancies; and group III (n=13) was IVF patients with normal appearance of the ovaries by ultrasound. The endocrine status was compared with the IVF results.
Results: There was no difference among groups in the endocrinological parameters tested, except for the OGTT which identified women in group I as having higher serum glucose and insulin levels than patients in groups II and III. Similarly, the OGTT showed higher serum glucose values in group II compared to group III. Women in group I were also obese. Patients in group III were older than PCO patients and needed more gonadotropins to reach an ovarian response which resulted in a reduced number of oocytes retrieved. Fertilization was also impaired in group I, in which no pregnancy was recorded.
Conclusions: This study shows that there is a particular subgroup of PCO patients with lower fertilization rates and embryos unable to implant. These patients are obese and nonhyperandrogenic and show derangements of insulin secretion.
Key Words: polycystic ovary, oocyte quality, insulin resistance, in vitro fertilization, insulin, glucose
Full Text
The Full Text of this article is available as a PDF (737.7 KB).
References
- 1.Salat-Baroux J, Alvarez S, Antoine JM, Cornet D, Tibi Ch, Plachot M, Mandelbaum J. Results of IVF in the treatment of polycystic ovary disease. Hum Reprod. 1988;3:331–335. doi: 10.1093/oxfordjournals.humrep.a136704. [DOI] [PubMed] [Google Scholar]
- 2.Dor J, Shulman A, Levran D, Ben-Rafael Z, Rudak E, Mashiach S. The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: A comparison of results with those of patients with tubal infertility. Hum Reprod. 1990;5:816–818. doi: 10.1093/oxfordjournals.humrep.a137189. [DOI] [PubMed] [Google Scholar]
- 3.MacDougall MJ, Tan SL, Balen A, Jacobs HS. A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. Hum Reprod. 1993;8:233–237. doi: 10.1093/oxfordjournals.humrep.a138029. [DOI] [PubMed] [Google Scholar]
- 4.Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol. 1992;167:1807–1812. doi: 10.1016/0002-9378(92)91779-a. [DOI] [PubMed] [Google Scholar]
- 5.Balen AH, Conway GS, Kaltsas G, Techatraisak K, Manning PJ, West Ch, Jacobs HS. Polycystic ovary syndrome: The spectrum of the disorder in 1741 patients. Hum Reprod. 1995;10:2107–2111. doi: 10.1093/oxfordjournals.humrep.a136243. [DOI] [PubMed] [Google Scholar]
- 6.Polson DW, Wadsworth J, Adams J, Franks S. Polycystic ovaries—a common finding in normal women. Lancet. 1988;2:870–872. doi: 10.1016/S0140-6736(88)91612-1. [DOI] [PubMed] [Google Scholar]
- 7.Wong IL, Morris RS, Lobo RA, Paulson RJ, Sauer MV. Isolated polycystic morphology in ovum donors predicts response to ovarian stimulation. Hum Reprod. 1995;10:524–528. doi: 10.1093/oxfordjournals.humrep.a135982. [DOI] [PubMed] [Google Scholar]
- 8.Pellicer A, Ruiz A, Castellví RM, Calatayud C, Ruiz M, Tarín JJ, et al. Is the retrieval of high numbers of oocytes desirable in patients treated with gonadotrophin-releasing hormone analogues (GnRHa) and gonadotrophins? Hum Reprod. 1989;4:536–540. doi: 10.1093/oxfordjournals.humrep.a136940. [DOI] [PubMed] [Google Scholar]
- 9.Testart J, Belaisch-Allart J, Forman R, Gazengel A, Hazout A, Strubb N, Frydman R. Influence of different stimulation treatments on oocyte characteristics and in vitro fertilizing ability. Hum Reprod. 1989;4:192–197. doi: 10.1093/oxfordjournals.humrep.a136870. [DOI] [PubMed] [Google Scholar]
- 10.Remohí J, Vidal A, Pellicer A. Oocyte donation in low responders to conventional ovarian stimulation for in vitro fertilization. Fertil Steril. 1993;59:1208–1215. doi: 10.1016/s0015-0282(16)55978-0. [DOI] [PubMed] [Google Scholar]
- 11.Ashkenazi J, Farhi J, Orvieto R, Homburg R, Dekel A, Feldberg D, Ben Rafael Z. Polycystic ovary syndrome patients as oocyte donors: the effect of ovarian stimulation protocol on the implantation rate of the recipient. Fertil Steril. 1995;64:564–567. doi: 10.1016/s0015-0282(16)57793-0. [DOI] [PubMed] [Google Scholar]
- 12.Simón C, Cano F, Valbuena D, Remohí J, Pellicer A. Clinical evidence for a detrimental effect on uterine receptivity of high serum estradiol levels in high and normal responder patients. Hum Reprod. 1995;10:2432–2437. doi: 10.1093/oxfordjournals.humrep.a136313. [DOI] [PubMed] [Google Scholar]
- 13.Hardy K, Robinson FM, Paraschos T, Wicks R, Franks S, Winston RML. Normal development and metabolic activity of preimplantation embryos in vitro from patients with polycystic ovaries. Hum Reprod. 1995;10:2125–2135. doi: 10.1093/oxfordjournals.humrep.a136247. [DOI] [PubMed] [Google Scholar]
- 14.Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. 3rd ed. Cambridge: Cambridge University Press; 1992. pp. 43–44. [Google Scholar]
- 15.Pasquali R, Antenucci D, Venturoli S, et al. Insulin resistance in patients with polycystic ovaries: its relationship to body weight and androgen levels. Acta Endocrinol (Copenh) 1983;104:110–116. doi: 10.1530/acta.0.1040110. [DOI] [PubMed] [Google Scholar]
- 16.Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes. 1992;41:1257–1266. doi: 10.2337/diabetes.41.10.1257. [DOI] [PubMed] [Google Scholar]
- 17.Willis D, Franks S. Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insilin-like growth factor receptor. J Clin Endocrinol Metab. 1995;80:3788–3790. doi: 10.1210/jc.80.12.3788. [DOI] [PubMed] [Google Scholar]
- 18.Baulieu EE. Induction by progesterone and a “maturation-promoting factor” of soluble protein in xenopus laevis oocytes in vitro. Ann NY Acad Sci. 1977;286:421–433. doi: 10.1111/j.1749-6632.1977.tb29434.x. [DOI] [PubMed] [Google Scholar]
- 19.Silverberg KM, Burns WN, Olive DL, Riehl RM, Schenken RS. Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. J Clin Endocrinol Metab. 1991;73:797–803. doi: 10.1210/jcem-73-4-797. [DOI] [PubMed] [Google Scholar]
- 20.Andersen CY. Characteristics of human follicular fluid associated with successful conception after in vitro fertilization. J Clin Endocrinol Metab. 1993;77:1227–1234. doi: 10.1210/jc.77.5.1227. [DOI] [PubMed] [Google Scholar]
- 21.Gómez E, Tarín JJ, Pellicer A. Oocyte maturation in humans: Effect of gonadotropins and growth factors. Fertil Steril. 1993;60:40–46. [PubMed] [Google Scholar]
- 22.Filicori M, Flamigni C, Cognigni G, Dellai P, Michelacci L, Arnone R. Increased insulin secretion in patients with multifollicular and polycystic ovaries and its impact on ovulation induction. Fertil Steril. 1994;62:279–285. doi: 10.1016/s0015-0282(16)56879-4. [DOI] [PubMed] [Google Scholar]
- 23.Homburg R. Polycystic ovary syndrome—from gynaecological curiosity to multisystem endocrinopathy. Hum Reprod. 1997;11:29–39. doi: 10.1093/oxfordjournals.humrep.a019031. [DOI] [PubMed] [Google Scholar]
- 24.Homburg R, Armar NA, Eshel A, Adams J, Jacobs HS. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. Br Med J. 1988;297:1024–1026. doi: 10.1136/bmj.297.6655.1024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Pellicer A, Valbuena D, Cano F, Remohí J, Simón C. Lower implantation rates in high responders: Evidence for an altered endocrine milieu during the pre-implantation period. Fertil Steril. 1997;65:1190–1195. doi: 10.1016/s0015-0282(16)58337-x. [DOI] [PubMed] [Google Scholar]